Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H21N5OS |
| Molecular Weight | 343.447 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)C1=CC=NC2=C1C3=C(S2)C(=O)N(C=N3)N4CCCCCC4
InChI
InChIKey=GYWGXEGOXODOQU-UHFFFAOYSA-N
InChI=1S/C17H21N5OS/c1-20(2)12-7-8-18-16-13(12)14-15(24-16)17(23)22(11-19-14)21-9-5-3-4-6-10-21/h7-8,11H,3-6,9-10H2,1-2H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17016515 | http://adisinsight.springer.com/drugs/800024545Curator's Comment: Description was created based on several sources, includinghttps://www.ncbi.nlm.nih.gov/pubmed/17551319
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17016515 | http://adisinsight.springer.com/drugs/800024545
Curator's Comment: Description was created based on several sources, includinghttps://www.ncbi.nlm.nih.gov/pubmed/17551319
A-841720, a novel, potent and non-competitive mGluR1 antagonist in models of pain and of motor and cognitive function, is being under development by Merz Pharmaceuticals GmbH. It is a selective non-competitive mGlu1 receptor antagonist (IC50: 10 nM); showing 34-fold selectivity over mGluR5 and no significant activity at other mGluR receptors, neurotransmitter receptors, ion channels, and transporters. A-841720 demonstrated full efficacy in various in vivo animal pain models.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3772 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17016515 |
10.7 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Analgesic activity of metabotropic glutamate receptor 1 antagonists on spontaneous post-operative pain in rats. | 2008-02-12 |
|
| Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists. | 2006-09-15 |
|
| Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists. | 2005-11-17 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17551319
A-841720 significantly reduced formalin-induced behaviours,
such as hindpaw flinching and licking, at the doses
of 10 and 30 mg/kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17016515
At recombinant human and native rat mGluR1 receptors, A-841720 inhibited agonist-induced calcium mobilization, with IC50 values of 10.7+/-3.9 and 1.0 +/- 0.2 nM
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
869802-58-4
Created by
admin on Mon Mar 31 23:00:06 GMT 2025 , Edited by admin on Mon Mar 31 23:00:06 GMT 2025
|
PRIMARY | |||
|
DTXSID10236030
Created by
admin on Mon Mar 31 23:00:06 GMT 2025 , Edited by admin on Mon Mar 31 23:00:06 GMT 2025
|
PRIMARY | |||
|
U8C5C9D65S
Created by
admin on Mon Mar 31 23:00:06 GMT 2025 , Edited by admin on Mon Mar 31 23:00:06 GMT 2025
|
PRIMARY | |||
|
11559235
Created by
admin on Mon Mar 31 23:00:06 GMT 2025 , Edited by admin on Mon Mar 31 23:00:06 GMT 2025
|
PRIMARY |
ACTIVE MOIETY